Latest News

High and low HDL cholesterol levels linked to dementia risk


 

TOPLINE:

High and low levels of HDL cholesterol but not levels of LDL cholesterol are associated with an increased risk for dementia in older adults, a new study found.

METHODOLOGY:

  • Electronic health record and survey data on 184,367 Kaiser Permanente Northern California participants (median age, 69.5 years) with no history of dementia were taken.
  • Cholesterol levels were measured within 2 years of survey completion.

TAKEAWAY:

  • There were 25,214 incident cases of dementia reported over an average follow-up of 8.77 years.
  • Dementia risk was significantly higher in people with low HDL cholesterol (11-41 mg/dL; adjusted hazard ratio, 1.07; 95% confidence interval, 1.03-1.11) and high HDL cholesterol (> 65 mg/dL; aHR, 1.15; 95% CI, 1.11-1.20).
  • The study demonstrates an association between low and high levels of “good” cholesterol but not a causal link.
  • There was no significant association between LDL cholesterol and dementia risk.

IN PRACTICE:

“These results support the conclusion that some lipoproteins may be modifiable risk factors for dementia, even in late life,” the authors wrote.

SOURCE:

The study was conducted by Erin L. Ferguson, MPH, department of epidemiology & biostatistics, University of California, San Francisco, and was funded by the National Institutes of Health. It was published online in Neurology.

LIMITATIONS:

There were no adjustments for apo E status and confounding and selection bias.

DISCLOSURES:

The authors report no relevant disclosures.

A version of this article first appeared on Medscape.com.

Recommended Reading

Loneliness tied to increased risk for Parkinson’s disease
MDedge Internal Medicine
Hyperbaric oxygen therapy for traumatic brain injury: Promising or wishful thinking?
MDedge Internal Medicine
History of depression, stress tied to Alzheimer’s, MCI risk
MDedge Internal Medicine
Lead pollutants as harmful to health as particulate matter
MDedge Internal Medicine
A new clue into the cause, spread of Parkinson’s disease?
MDedge Internal Medicine
Proton pump inhibitors linked to increased dementia risk
MDedge Internal Medicine
Guillain-Barré syndrome: Honing treatment strategies
MDedge Internal Medicine
New guidelines for determining brain death released
MDedge Internal Medicine
Pragmatic solutions to ‘catastrophic’ global stroke burden
MDedge Internal Medicine
Obesity linked to multiple ills in MS study
MDedge Internal Medicine